For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Product sourcing reference

DSIP

Delta sleep-inducing peptide is a nonapeptide with mixed and dated research. Review the evidence before accepting sleep-related claims.

Reference variants

Add DSIP to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

  • 10mgVial · confirm physical formCAS 62568-57-4
    $25.88/vial$20.70/vial at 1,000+ vials of this item
    vials, packs of 10
  • 15mgSpray bottleCAS 62568-57-4
    $30.00/bottle$20.00/bottle at 50+ bottles of this item
    bottles

Review your order request · Compare the full catalog

Confirm the exact substance

DSIP was isolated in the 1970s; later studies did not consistently confirm its effects. The vial and spray formats are different preparations.

What the review will ask

There is no approved DSIP product. Ask the requester to state the intended use for the eligibility review.

  • State the facility type, destination state and intended transaction. Do not send patient information.
  • Expect product- and lot-specific documentation to be requested before any material is accepted.
  • A listed price is a reference estimate. Availability, labeling, shipping and terms are confirmed in writing only after review.

Purchasing questions

Is DSIP proven to improve sleep?

No. Human study results are inconsistent and do not establish a reliable clinical effect.

Reconcile DSIP and emideltide names

FDA identifies emideltide as DSIP and describes missing safety information for the proposed route. A sleep-related name does not establish a supported clinical outcome.

Documentation to request

Request identity documentation using both names where applicable, and compare the vial and spray as different finished preparations.

Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Non-clinical protocol review checklist. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. This reference is not medical or legal advice and does not establish a lawful supply route.

Discuss sourcing requirements
Call Apply for Wholesale